Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Metastatic Adenocarcinoma of the Colon or Rectum, Malignant Solid Tumors.
Sponsors: Baxalta now part of Shire.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has 1 clinical trials on record. Their work covers Metastatic Adenocarcinoma of the Colon or Rectum, Malignant Solid Tumors.
Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.